Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

IBERE PHARMACEUTICALS (IBER) — insider trading: 1 buys, 0 sells · InsiderLens

Home / Companies / IBERE PHARMACEUTICALS

IBERE PHARMACEUTICALS

IBER

Insider trading at IBERE PHARMACEUTICALS

Transactions on record: 1; since Mar 2, 2021

Insider buys: 1; $100K

Insider sells: 0

Active insiders · 12 months: 0; last filing Mar 2, 2021

Figures computed from official regulatory filings — methodology.

Current insiders at IBERE PHARMACEUTICALS

Gray Lisa M.Director
Gray Lisa M.Chief Financial Officer
Gray Lisa M.10% owner
IMASOGIE OSAGIE ODirector
IMASOGIE OSAGIE OChief Executive Officer
IMASOGIE OSAGIE O10% owner
Johnson Calvin B.Director
Jones Elaine VDirector
Kerekes ZoltanDirector
Kerekes ZoltanChief Operating Officer
Kerekes Zoltan10% owner
PIPV Capital LLC10% owner
UKWU HENRIETTADirector
Vollmer Louis J.Director

Insider transaction history at IBERE PHARMACEUTICALS

Insider	Filed	Type	Qty	Price	Value · USD	Src
Vollmer Louis J.	Mar 2, 2021	Buy	10,000	10.00 USD	$100K	SEC